What Is Tirzepatide?
Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist. You probably know it by its brand names: Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management). It was developed by Eli Lilly, and it has become one of the most searched compounds in the peptide space — for good reason.
In clinical trials, tirzepatide produced weight loss results that surpassed every other GLP-1 drug on the market. The SURMOUNT-1 trial showed participants losing an average of 22.5% of body weight at the highest dose over 72 weeks. That is not a typo. No pharmaceutical weight loss intervention has come close to those numbers before.
The catch? Brand-name tirzepatide costs over $1,000/month without insurance. That price tag has driven enormous demand for alternatives — compounding pharmacies, telehealth clinics, and research peptide vendors.
Here is what the data shows across every route.
Legal Status — This Is Not a Grey Area
Unlike most peptides discussed on this site, tirzepatide is FDA-approved. This is an important distinction.
- •Brand-name Mounjaro/Zepbound: Available by prescription at retail pharmacies. Covered by some insurance plans, particularly for diabetes.
- •Compounded tirzepatide: Available from FDA-registered 503A and 503B compounding pharmacies, prescribed by licensed clinicians. The FDA has allowed compounding of tirzepatide during the ongoing drug shortage.
- •Research-grade tirzepatide: Available from research peptide vendors, labeled "for research use only."
The prescription route through a telehealth clinic is fully legal and provides medical oversight. For a compound with this level of FDA scrutiny and clinical data, that matters.
For more on the evolving legal landscape, see our [guide to peptide legality in 2026](/blog/are-peptides-legal-2026-guide).
Tirzepatide vs Semaglutide — The Comparison Everyone Wants
This is the matchup that dominates search results, Reddit threads, and clinic consultations. Both are injectable GLP-1 receptor agonists used for weight loss. But they work differently.
| Factor | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual GIP + GLP-1 agonist | GLP-1 agonist only |
| Brand names | Mounjaro, Zepbound | Ozempic, Wegovy |
| Avg weight loss (trials) | 22.5% body weight | 14.9% body weight |
| FDA-approved for weight loss | Yes (Zepbound) | Yes (Wegovy) |
| Injection frequency | Once weekly | Once weekly |
| GI side effects | Similar (nausea, diarrhea) | Similar (nausea, diarrhea) |
| Cost (brand, no insurance) | ~$1,000-1,100/mo | ~$900-1,300/mo |
| Compounded availability | Yes (during shortage) | Yes |
The dual-agonist mechanism is what separates tirzepatide. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are both incretin hormones, but they activate different receptor pathways. Tirzepatide hits both. The clinical data suggests this dual approach produces meaningfully better outcomes — not just for weight loss, but for glycemic control, insulin sensitivity, and cardiovascular risk markers.
That said, [semaglutide](/compounds/semaglutide) has a longer track record and more post-market safety data. Some clinicians still prefer starting patients on semaglutide and switching to tirzepatide if results plateau.
For a deeper dive into the compound profiles, see our [tirzepatide compound page](/compounds/tirzepatide) and [semaglutide compound page](/compounds/semaglutide).
Clinic Comparison — Where to Get Prescribed Tirzepatide
Telehealth clinics have made tirzepatide accessible without the traditional doctor-visit bottleneck. Here is how the major providers compare.
| Clinic | PV Score | Monthly Cost | Trustpilot | States | Notes |
|---|---|---|---|---|---|
| [Peter MD](/clinics/peter-md) | 8.2/10 | $150-400 | 4.8★ (13,947 reviews) | Most states | Highest-rated, competitive pricing |
| [Hims & Hers](/clinics/hims-and-hers) | 7.5/10 | $199-299 | — | All 50 states | Largest platform, GLP-1 program |
| Relive Health | 7.2/10 | $200-500 | — | Select states | Hybrid in-person + telehealth model |
| Viking Alternative | 6.8/10 | $100-350 | — | Most states | Budget option, wider price range |
| The Protocole | 6.5/10 | $150-400 | — | Select states | Newer entrant |
Key takeaways from the clinic data:
- •Peter MD stands out with 13,947 Trustpilot reviews at 4.8 stars — that volume of social proof is rare in the telehealth peptide space. Pricing starts at $150/month, which undercuts most competitors.
- •Hims & Hers offers nationwide coverage across all 50 states, which matters if you live somewhere with limited telehealth options. Their GLP-1 program is priced at $199-299/month.
- •Viking Alternative has the lowest floor price at $100/month, though the range is wide and actual cost depends on dosing protocol.
All of these clinics source from FDA-registered compounding pharmacies and include medical consultation in their pricing. Browse our full [clinic directory](/clinics) for more options.
How Tirzepatide Works — The Science
Tirzepatide is a 39-amino-acid synthetic peptide that mimics two naturally occurring hormones:
GLP-1 (Glucagon-Like Peptide-1): - Slows gastric emptying (you feel full longer) - Stimulates insulin secretion in response to food - Suppresses glucagon release - Acts on brain appetite centers to reduce hunger
GIP (Glucose-Dependent Insulinotropic Polypeptide): - Enhances insulin sensitivity - May improve fat metabolism and energy expenditure - Complements GLP-1 effects through a separate receptor pathway
Clinical Trial Results (SURMOUNT Program)
The SURMOUNT trials are what put tirzepatide on the map for weight loss:
- •SURMOUNT-1 (2022): 2,539 adults with obesity, no diabetes. At the 15mg dose, participants lost an average of 22.5% of body weight over 72 weeks. 63% of participants lost more than 20% of their body weight.
- •SURMOUNT-2 (2023): Adults with obesity AND type 2 diabetes. Average weight loss of 14.7% at the highest dose — significant because weight loss is typically harder with diabetes.
- •SURMOUNT-3 (2023): Combined with intensive lifestyle intervention. Average weight loss of 26.6% — the highest ever recorded in a pharmaceutical trial.
- •SURMOUNT-4 (2023): Withdrawal study. Participants who stopped tirzepatide regained approximately half the weight they had lost over 52 weeks, confirming that ongoing treatment is needed to maintain results.
These are not cherry-picked numbers. They are from large, randomized, double-blind, placebo-controlled trials published in the New England Journal of Medicine.
Research Vendor Pricing
For researchers studying tirzepatide, several vendors carry the compound in lyophilized form. Here is current pricing from vendors in our database.
| Vendor | Amount | Price | Price/mg | Finnrick Rating |
|---|---|---|---|---|
| Paradigm Peptides | 10mg | $80.00 | $8.00/mg | A |
| Paradigm Peptides | 30mg | $149.00 | $4.97/mg | A |
| Paradigm Peptides | 60mg | $300.00 | $5.00/mg | A |
| Polaris Peptides | 10mg | $99.00 | $9.90/mg | A |
| Polaris Peptides | 30mg | $250.00 | $8.33/mg | A |
| Polaris Peptides | 50mg | $320.00 | $6.40/mg | A |
| Polaris Peptides | 60mg | $360.00 | $6.00/mg | A |
| Peptide Partners | 40mg | $297.00 | $7.43/mg | — |
Best value: Paradigm Peptides at $4.97/mg for the 30mg vial. Both Paradigm and Polaris carry Finnrick A ratings, which indicates verified third-party purity testing.
Browse pricing across all compounds and vendors on our [vendor directory](/vendors).
Important note: Research peptides are sold for laboratory research purposes only. Tirzepatide is an FDA-approved drug, and for individuals seeking it for personal use, the prescription route through a licensed clinic is the appropriate path.
The Bottom Line
Tirzepatide is the most effective weight loss pharmaceutical currently available. The clinical data is unambiguous. Unlike most compounds discussed on this site, it has full FDA approval, extensive safety data, and legitimate prescription pathways.
Our recommendation is straightforward: go through a clinic.
Here is why:
- •It is FDA-approved. You do not need to navigate the grey market for this compound.
- •Clinic pricing has dropped significantly. At $150-300/month through telehealth, the cost gap between clinics and research vendors is narrower than you might expect — especially when you factor in medical oversight, proper dosing guidance, and legal protection.
- •You get pharmaceutical-grade product. Compounding pharmacies operate under FDA registration with sterility and potency testing requirements that no research vendor can match.
- •Medical monitoring matters. Tirzepatide affects insulin signaling, gastric function, and body composition. Having a clinician track your labs and adjust dosing is not optional — it is the responsible approach.
For researchers studying tirzepatide in a laboratory setting, the vendor pricing data above provides a starting point. Check our [tirzepatide compound page](/compounds/tirzepatide) for COA data and purity comparisons.
For everyone else: [find a clinic](/clinics), get a prescription, and do this the right way. The era of needing grey market vendors for FDA-approved peptides is ending.